Top Markets
Coin of the day
Avisa Diagnostics Inc. Avisa Diagnostics Inc.

Avisa Diagnostics Inc.

AVBT
Rank in Stocks #40597
Avisa Diagnostics Inc., a clinical-stage medical device company based in Santa... Avisa Diagnostics Inc., a clinical-stage medical device company based in Santa Fe, New Mexico, is dedicated to developing the Avisa BreathTest. This innovative drug/device biomarker technology platform is designed for the ultra-rapid identification of virulent bacterial pathogens and the subsequent monitoring of bacterial load. The system works by analyzing a patient's breath after they have inhaled or ingested Avisa's proprietary drug substrates. The company has already established clinical proof-of-concept through trials in conditions such as cystic fibrosis, tuberculosis, and community-acquired pneumonia, and is now concentrating on pivotal trials for Post-COVID-19 bronchiectasis and ventilator-associated pneumonia.
Share Price
$0.0333321
Last synced: 2023-05-23
Market Cap
$114.40K
Change (1 day)
-0.04%
Change (1 year)
0.00%
Country
US
Trade Avisa Diagnostics Inc. (AVBT)

Category

Revenue for Avisa Diagnostics Inc. (AVBT)
Revenue in Aug 2026 TTM: 0
According to Avisa Diagnostics Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Avisa Diagnostics Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$46.59B -
US
$25.84B -
US
$35.48B -
IE
$21.00B -
US
$6.51B -
US